Senate adopts user fee bill in rare 'Kumbaya' moment

In what Senate Majority Leader Harry Reid (Democrat-Nevada) declared a “good day in Washington,” the US Senate on 24 May came together in a rare bipartisan move to adopt the legislative package aimed at ensuring the US FDA can continue to collect user fees from drug and device makers, with new fees from generic and biosimilar manufacturers.